WO2000066577A3 - Brigded cycloalkanes as thromboxane ligands without blood clotting effects - Google Patents
Brigded cycloalkanes as thromboxane ligands without blood clotting effects Download PDFInfo
- Publication number
- WO2000066577A3 WO2000066577A3 PCT/US2000/011760 US0011760W WO0066577A3 WO 2000066577 A3 WO2000066577 A3 WO 2000066577A3 US 0011760 W US0011760 W US 0011760W WO 0066577 A3 WO0066577 A3 WO 0066577A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- radical
- group
- radicals
- aryl
- hemorrhage
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU46875/00A AU4687500A (en) | 1999-04-29 | 2000-04-27 | Thromboxane ligands without blood clotting side effects |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30179499A | 1999-04-29 | 1999-04-29 | |
US09/301,794 | 1999-04-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000066577A2 WO2000066577A2 (en) | 2000-11-09 |
WO2000066577A3 true WO2000066577A3 (en) | 2001-03-01 |
Family
ID=23164906
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/011760 WO2000066577A2 (en) | 1999-04-29 | 2000-04-27 | Brigded cycloalkanes as thromboxane ligands without blood clotting effects |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4687500A (en) |
WO (1) | WO2000066577A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0201837D0 (en) * | 2002-06-14 | 2002-06-14 | Astrazeneca Ab | Chemical compounds |
AP2016009502A0 (en) | 2014-05-13 | 2016-10-31 | Novartis Ag | Compounds and compositions for inducing chondrogenesis |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4438136A (en) * | 1979-01-05 | 1984-03-20 | National Research Development Corporation | Prostaglandins |
US4654364A (en) * | 1984-11-30 | 1987-03-31 | E. R. Squibb & Sons, Inc. | Hydroxamic acids of 7-oxabicycloheptane substituted ethers |
JPS63284158A (en) * | 1987-05-18 | 1988-11-21 | Shionogi & Co Ltd | Phenylsulfonylaminoalkylbicycloheptylheptenoic acid derivative |
US4942256A (en) * | 1988-12-13 | 1990-07-17 | National Research Development Corporation | Novel intermediates in the manufacture of novel thromboxane A2 antagonists |
DE4013680A1 (en) * | 1989-05-01 | 1990-11-08 | Squibb & Sons Inc | THROMBOXAN-A (ARROW DOWN) 2 (ARROW ABSTRACT) RECEPTOR ANTAGONISTS FOR INHIBITING VASOSPASM AND THROMBOCYTE AGGREGATION BASED ON ANGIOPLASTY |
US4973604A (en) * | 1988-12-13 | 1990-11-27 | National Research Development Corporation | Thromboxane A2 antagonists and pharmaceutical compositions thereof |
US4977174A (en) * | 1989-06-12 | 1990-12-11 | E. R. Squibb & Sons, Inc. | 7-oxabicycloheptane imidazole prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease |
JPH0377862A (en) * | 1989-08-18 | 1991-04-03 | Ono Pharmaceut Co Ltd | Bicyclo(2,2,1)heptane derivative, purification and its production |
WO1995018103A1 (en) * | 1993-12-28 | 1995-07-06 | Allergan | 7-[carboxyalkyl or alkenyl]-6-[alkyl or alkenyl] 3-oxo-2,4-dioxobicyclo-[3.2.1] octane and derivatives thereof |
US5650431A (en) * | 1993-12-28 | 1997-07-22 | Allergan | Thromboxane ligands without blood clotting side effects |
US5741812A (en) * | 1993-12-28 | 1998-04-21 | Allergan | Thromboxane ligands without blood clotting side effects |
WO1999012921A1 (en) * | 1997-09-09 | 1999-03-18 | Allergan Sales, Inc. | Thromboxane ligands |
-
2000
- 2000-04-27 WO PCT/US2000/011760 patent/WO2000066577A2/en active Application Filing
- 2000-04-27 AU AU46875/00A patent/AU4687500A/en not_active Abandoned
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4438136A (en) * | 1979-01-05 | 1984-03-20 | National Research Development Corporation | Prostaglandins |
US4654364A (en) * | 1984-11-30 | 1987-03-31 | E. R. Squibb & Sons, Inc. | Hydroxamic acids of 7-oxabicycloheptane substituted ethers |
JPS63284158A (en) * | 1987-05-18 | 1988-11-21 | Shionogi & Co Ltd | Phenylsulfonylaminoalkylbicycloheptylheptenoic acid derivative |
US4942256A (en) * | 1988-12-13 | 1990-07-17 | National Research Development Corporation | Novel intermediates in the manufacture of novel thromboxane A2 antagonists |
US4973604A (en) * | 1988-12-13 | 1990-11-27 | National Research Development Corporation | Thromboxane A2 antagonists and pharmaceutical compositions thereof |
DE4013680A1 (en) * | 1989-05-01 | 1990-11-08 | Squibb & Sons Inc | THROMBOXAN-A (ARROW DOWN) 2 (ARROW ABSTRACT) RECEPTOR ANTAGONISTS FOR INHIBITING VASOSPASM AND THROMBOCYTE AGGREGATION BASED ON ANGIOPLASTY |
US4977174A (en) * | 1989-06-12 | 1990-12-11 | E. R. Squibb & Sons, Inc. | 7-oxabicycloheptane imidazole prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease |
JPH0377862A (en) * | 1989-08-18 | 1991-04-03 | Ono Pharmaceut Co Ltd | Bicyclo(2,2,1)heptane derivative, purification and its production |
WO1995018103A1 (en) * | 1993-12-28 | 1995-07-06 | Allergan | 7-[carboxyalkyl or alkenyl]-6-[alkyl or alkenyl] 3-oxo-2,4-dioxobicyclo-[3.2.1] octane and derivatives thereof |
US5516791A (en) * | 1993-12-28 | 1996-05-14 | Allergan | 7-[carboxyakyl or alkenyl]-6-[alkyl or alkenyl]3-oxo-2,4-dioxobicyclo-[3.2.1]octane and derivatives thereof |
US5650431A (en) * | 1993-12-28 | 1997-07-22 | Allergan | Thromboxane ligands without blood clotting side effects |
US5741812A (en) * | 1993-12-28 | 1998-04-21 | Allergan | Thromboxane ligands without blood clotting side effects |
WO1999012921A1 (en) * | 1997-09-09 | 1999-03-18 | Allergan Sales, Inc. | Thromboxane ligands |
Non-Patent Citations (2)
Title |
---|
PATENT ABSTRACTS OF JAPAN vol. 013, no. 107 14 March 1989 (1989-03-14) * |
PATENT ABSTRACTS OF JAPAN vol. 015, no. 248 25 June 1991 (1991-06-25) * |
Also Published As
Publication number | Publication date |
---|---|
WO2000066577A2 (en) | 2000-11-09 |
AU4687500A (en) | 2000-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1052254A4 (en) | Nitrogenous heterocyclic derivatives and medicine thereof | |
RU2006105804A (en) | NITROOXY-DERIVATIVES OF LOZARTAN, VALSARTAN, CANdesARTHAN, TELMISARTAN, EPROSARTAN AND OLMESARTAN AS ANGIOTENZENE II RECEPTOR BLOCKS FOR HEART CEREAL | |
KR960033460A (en) | Pharmaceutical composition for the treatment of inflammatory diseases of the heart | |
WO2001091797A3 (en) | Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds | |
EA200200299A1 (en) | NEW α-AMINO ACID SULPHONYL COMPOUNDS, METHOD OF THEIR RECEIVING AND PHARMACEUTICAL COMPOSITIONS THEIR CONTAINING | |
RU99106522A (en) | SUBSTITUTED CYCLIC AMINUM METHODIC PROTEASIS INHIBITORS | |
CA2551409A1 (en) | Prostaglandin nitrooxyderivatives | |
WO2001040149A3 (en) | Inhibition of polymerization of unsaturated monomers | |
JP2005504011A5 (en) | ||
CA2493995A1 (en) | Macrolide compounds endowed with antiinflammatory activity | |
NZ296524A (en) | 2,2-Dichloroalkane carboxylic acids, preparation and pharmaceutical compositions | |
KR900001718A (en) | Aninoalkylaminocarbonyl aminodiol amino acid derivatives as antihypertensive agents | |
RU2005115964A (en) | 1- (4-BENZYLPIPERAZIN-1-IL) -3-PENYLPROPENONE DERIVATIVES | |
WO2001057021A3 (en) | 2-[1H]-QUINOLONE AND 2-[1H]-QUINOXALONE INHIBITORS OF FACTOR Xa | |
WO2000066577A3 (en) | Brigded cycloalkanes as thromboxane ligands without blood clotting effects | |
AR050043A1 (en) | METHODS TO IMPROVE BIODISPONIBILITY AND PHARMACEUTICAL COMPOSITION FOR CARDIOVASCULAR DISORDERS | |
WO2004071428A3 (en) | 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure | |
KR950704325A (en) | Diaryl 5,6-fusesheterocyclic acids as leukotriene antagonists as leukotriene antagonists | |
WO2006113571B1 (en) | Substituted cyclopentanones for treating inflammatory bowel disease | |
WO2006121822B1 (en) | USE OF β-LACTAMS FOR THE TREATMENTOF IBD AND GLAUCOMA | |
EA007068B1 (en) | 3-methyl-dihydro-ziprasidone for treatment of psychiatric disorders | |
DE69010757D1 (en) | Phenylalkanolic acid ester. | |
KR910015571A (en) | Anti-inflammatory benzoxazolone | |
CA2244695A1 (en) | Cyclic amic acid derivatives | |
HUP0101503A2 (en) | Heterocycloalkyl- and heteroaryl-benzocyclobutane derivatives, process for their preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |